王丽 王馨 马文政 丁雪梅

【摘要】 目的:探討益气活血汤在慢性肾小球肾炎脾肾气阴两虚兼湿浊的临床疗效及对患者不良反应发生率的影响。方法:选取2018年4月-2020年10月本院收治的142例慢性肾小球肾炎患者为对象,按照随机数字表法将患者分为西药组和治疗组,各71例。西药组采用缬沙坦分散片治疗,治疗组采用缬沙坦分散片联合益气活血汤治疗。比较两组的症候积分、肾损害指标水平及不良反应发生情况。结果:治疗12周后,两组症候积分均低于治疗前(P<0.05);且治疗组治疗12周后的身重困倦、脘腹胀满、食少纳呆、小便赤浊及口中黏腻评分均低于西药组(P<0.05)。两组治疗12周后肾损害指标水平均低于治疗前(P<0.05);且治疗组治疗12周后的ACR、Scr、BUN、α1-MG、UNAG水平均低于西药组(P<0.05)。两组用药期间不良反应发生率比较,差异无统计学意义(P>0.05)。结论:益气活血汤用于慢性肾小球肾炎脾肾气阴两虚兼湿浊患者中,可降低症候积分,减轻肾损害,未且增加不良反应发生率,值得推广应用。
【关键词】 益气活血汤 慢性肾小球肾炎 气阴两虚 不良反应 肾损害
Effect of Yiqi Huoxue Decoction in the Treatment of Chronic Glomerulonephritis with Deficiency of Both Spleen and Kidney Qi and Yin and Dampness and Its Influence on the Occurrence of Adverse Reactions in Patients/WANG Li, WANG Xin, MA Wenzheng, DING Xuemei. //Medical Innovation of China, 2021, 18(16): 0-089
[Abstract] Objective: To investigate the clinical efficacy of Yiqi Huoxue Decoction in the treatment of chronic glomerulonephritis with deficiency of both spleen and kidney qi and yin and damp turbidity and its influence on the incidence of adverse reactions in patients. Method: A total of 142 patients with chronic glomerulonephritis admitted to our study from April 2018 to October 2020 were selected as the subjects. According to the random number table method, the patients were divided into western medicine group and treatment group, with 71 cases in each group. The western medicine group was treated with Valsartan Dispersible Tablets, and the treatment group was treated with Valsartan Dispersible Tablets combined with Yiqi Huoxue Decoction. The scores of syndromes, the level of renal damage indexes and the occurrence of adverse reactions of the two groups were compared. Result: After 12 weeks of treatment, the scores of syndromes in both groups were lower than those before treatment (P<0.05); and after 12 weeks of treatment in the treatment group, body weight, sleepiness, abdominal distension, poor appetite and appetite, turbid urine and sticky mouth scores were lower than those of the western medicine group (P<0.05). The kidney damage index levels after 12 weeks of treatment in the two groups were lower than those before treatment (P<0.05); and the levels of ACR, Scr, BUN, α1-MG, and UNAG in the treatment group after 12 weeks of treatment were lower than those in the western medicine group (P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups during the medication period (P>0.05). Conclusion: Yiqi Huoxue Decoction used in patients with chronic glomerulonephritis with deficiency of spleen and kidney qi and yin and dampness can reduce syndrome scores, reduce kidney damage, and increase the incidence of adverse reactions, it is worthy of popularization and application.
[Key words] Yiqi Huoxue Decoction Chronic glomerulonephritis Deficiency of both qi and yin Adverse reaction Renal damage
First-author’s address: Jiamusi Hospital of Traditional Chinese Medicine, Jiamusi 154002, China
doi:10.3969/j.issn.1674-4985.2021.16.021
慢性肾小球肾炎起病方式不同,病情迁延、病变缓慢进展,患者可伴有不同程度肾功能衰竭[1]。既往研究表明:慢性肾小球肾炎好发于青中年男性中,常见病因包括高血压、糖尿病及急性肾炎等,临床多表现为蛋白尿、高血压、水肿等,影响患者正常生活及健康[2]。缬沙坦分散片是慢性肾小球肾炎患者治疗中常用的西药,通过阻闭机体血管紧张素受体,有助于降低肾小球囊内高灌注、高滤过及高压力,能减缓肾小球病变硬化速度,利于病情的发展[3-4]。……